Responses
Case Reports: Findings that shed new light on the possible pathogenesis of a disease
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis
Compose a Response to This Article
Other responses
No responses have been published for this article.